Valganciclovir Hydrochloride
Product Images NDC 0904-7419

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 0904-7419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovir-50mg-100ml-cntr-label (Valganciclovir 50mg 100ml Cntr Label)

Label for Valganciclovir for Oral Solution 50 mg/mL by Major Pharmaceuticals. This label provides dosing preparation instructions, storage temperature guidelines, and a 100 mL (3.4 fl oz) bottle size. The product is Rx only and includes manufacturer and distributor information along with barcodes.*

FDA Label Image

Valganciclovir-50mg-100ml-crtn-label (Valganciclovir 50mg 100ml Crtn Label)

Valganciclovir for Oral Solution 50 mg/mL by Major Pharmaceuticals. The label indicates each mL of constituted oral solution contains 50 mg valganciclovir free base. Packaging is for 100 mL (3.4 fl oz) with NDC 0904-7419-04. The label includes dosage and storage instructions, Rx Only designation, and manufacturer information.*

FDA Label Image

Valganciclovir-dose-calculation-formula (Valganciclovir Dose Calculation Formula)

The image shows two medical formulas: the Mosteller Body Surface Area (BSA) calculation formula and the Schwartz Creatinine Clearance formula. The Mosteller BSA formula calculates body surface area in square meters using height in centimeters and weight in kilograms. The Schwartz formula estimates creatinine clearance in mL/min/1.73m² using a constant multiplied by height in centimeters divided by serum creatinine in mg/dL.*

FDA Label Image

Valganciclovir-fig-1 (Valganciclovir Fig 1)

Diagram illustrating components of an oral dispenser and bottle assembly for valganciclovir hydrochloride. The bottle includes a child-resistant cap, bottle adapter, and bottle. The oral dispenser consists of a plunger, barrel with measurement markings, and tip.*

FDA Label Image

Valganciclovir-fig-10 (Valganciclovir Fig 10)

An illustration showing a bottle with a tamper-evident cap and an arrow indicating the direction to open or remove the cap. The image depicts the removal process of the bottle cap for a pharmaceutical product.*

FDA Label Image

Valganciclovir-fig-11 (Valganciclovir Fig 11)

An instructional illustration showing a faucet with water droplets falling onto a syringe positioned below it, suggesting the syringe is being filled or rinsed with water from the faucet.*

FDA Label Image

Valganciclovir-fig-12 (Valganciclovir Fig 12)

Illustration of a medical syringe with volume markings from 1 to 10 milliliters. The syringe is shown in a side profile with a plunger and needle attachment end visible.*

FDA Label Image

Valganciclovir-fig-2 (Valganciclovir Fig 2)

An instructional illustration showing a hand holding a bottle with the text 'Shake well' and arrows indicating an up and down motion to demonstrate shaking the bottle thoroughly.*

FDA Label Image

Valganciclovir-fig-3 (Valganciclovir Fig 3)

An instructional line drawing depicting a vial bottle with an arrow pointing down onto the top, combined with a circular arrow around the top, indicating a twist and push action to open or close the vial cap.*

FDA Label Image

Valganciclovir-fig-4 (Valganciclovir Fig 4)

An illustration showing a syringe with a labeled dosage indicator in milliliters (mL), used to measure liquid medication doses accurately. The dosage indicator is marked on the syringe barrel with graduated measurements for precise dosing.*

FDA Label Image

Valganciclovir-fig-5 (Valganciclovir Fig 5)

An instructional illustration showing a hand holding a syringe-like device with an arrow indicating downward pressure on the plunger. The image likely demonstrates how to use a dosing syringe or oral dispenser for medication administration.*

FDA Label Image

Valganciclovir-fig-6 (Valganciclovir Fig 6)

An instructional diagram showing a hand inserting a bottle adapter into the opening of a medicine bottle. The image indicates the bottle adapter opening location with a label and an arrow pointing downward to guide the placement.*

FDA Label Image

Valganciclovir-fig-7 (Valganciclovir Fig 7)

An instructional illustration showing hands drawing liquid from a bottle using a syringe. The images depict positioning the bottle upside down and pulling the syringe plunger to fill it, indicating fluid measurement and extraction steps.*

FDA Label Image

Valganciclovir-fig-8 (Valganciclovir Fig 8)

An instructional black-and-white illustration showing a hand holding a syringe above a vial with an upward arrow, indicating the syringe is being withdrawn from the vial. No text or additional product details are visible.*

FDA Label Image

Valganciclovir-formula (Valganciclovir Formula)

A formula for males to calculate an estimated value involving age, body weight in kilograms, and serum creatinine in mg/dL. The formula is presented as (140 minus age in years) times body weight divided by 72 times the serum creatinine value.*

FDA Label Image

Valganciclovir-structural-formula (Valganciclovir Structural Formula)

Chemical structure of valganciclovir hydrochloride showing its molecular arrangement including heterocyclic rings, functional groups, and the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.